Vest Financial LLC Acquires 17,640 Shares of Dolby Laboratories $DLB

Key Points

• Vest Financial LLC increased its holdings in Dolby Laboratories by 156.1% in the second quarter, acquiring an additional 17,640 shares, bringing its total to 28,942 shares valued at approximately $2.15 million.
• Dolby Laboratories reported earnings of $0.78 per share for the last quarter, surpassing estimates, with revenue increase of 9.2% year-over-year.
• The company has announced a quarterly dividend of $0.33 per share, equating to an annual yield of 1.9%.

Vest Financial LLC boosted its holdings in Dolby Laboratories (NYSE:DLB - Free Report) by 156.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 28,942 shares of the electronics maker's stock after purchasing an additional 17,640 shares during the quarter. Vest Financial LLC's holdings in Dolby Laboratories were worth $2,149,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in DLB. Park Avenue Securities LLC bought a new stake in Dolby Laboratories in the first quarter worth approximately $222,000. Farther Finance Advisors LLC increased its holdings in shares of Dolby Laboratories by 239.3% during the first quarter. Farther Finance Advisors LLC now owns 743 shares of the electronics maker's stock valued at $60,000 after acquiring an additional 524 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Dolby Laboratories by 65.9% during the first quarter. GAMMA Investing LLC now owns 1,291 shares of the electronics maker's stock valued at $104,000 after acquiring an additional 513 shares in the last quarter. Fifth Third Bancorp increased its holdings in shares of Dolby Laboratories by 84.7% during the first quarter. Fifth Third Bancorp now owns 665 shares of the electronics maker's stock valued at $53,000 after acquiring an additional 305 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in shares of Dolby Laboratories by 114.6% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,141 shares of the electronics maker's stock valued at $975,000 after acquiring an additional 6,484 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.

Dolby Laboratories Stock Up 0.5%

Shares of NYSE:DLB opened at $69.11 on Wednesday. The stock has a market cap of $6.62 billion, a price-to-earnings ratio of 25.31 and a beta of 0.92. Dolby Laboratories has a 12-month low of $67.54 and a 12-month high of $89.66. The business's 50 day moving average is $72.07 and its 200 day moving average is $73.91.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company had revenue of $315.55 million for the quarter, compared to analysts' expectations of $305.23 million. During the same quarter in the previous year, the firm earned $0.71 earnings per share. Dolby Laboratories's quarterly revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, equities research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 annualized dividend and a yield of 1.9%. Dolby Laboratories's payout ratio is currently 48.35%.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of the business's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the transaction, the senior vice president owned 70,435 shares of the company's stock, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Yeaman sold 25,000 shares of the business's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $72.31, for a total value of $1,807,750.00. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $8,295,764.75. This represents a 17.89% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 57,000 shares of company stock worth $4,123,690. Insiders own 38.39% of the company's stock.

Analysts Set New Price Targets

DLB has been the subject of several recent research reports. Robert W. Baird initiated coverage on Dolby Laboratories in a report on Friday, September 5th. They set a "neutral" rating and a $74.00 price objective for the company. Rosenblatt Securities restated a "buy" rating and set a $95.00 price objective on shares of Dolby Laboratories in a report on Friday, August 1st. Baird R W upgraded Dolby Laboratories to a "hold" rating in a report on Friday, September 5th. Weiss Ratings restated a "hold (c)" rating on shares of Dolby Laboratories in a report on Wednesday, October 8th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, September 12th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $95.75.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.